The present invention relates to inhibitors of a non-long coding RNA and to pharmaceutical compositions comprising a non-long coding RNA inhibitor, which may further comprise an additional compound. The invention also relates to methods of treating a tumor and to methods of diagnosing and treating a tumor in a subject by using a long non-coding RNA and its inhibitors, and also to a method for increasing the migration of cytotoxic immune cells towards a tumor.
